KCNIP3 and cancer: Wang et al. reported that an analysis of 33 TCGA-based cancers showed an overall DREAM complex mutation rate of approximately 10% [92], with higher mutation rates only in a few cancers such as uterine corpus endometrial cancer, skin cutaneous melanoma, kidney renal clear cell carcinoma, and lung squamous cell carcinoma.